--- title: "Well Lead's subsidiary Hainan Well Lead has received a medical device registration certificate" type: "News" locale: "zh-CN" url: "https://longbridge.com/zh-CN/news/258825344.md" description: "According to the Zhitong Finance APP, Well Lead announced that its wholly-owned subsidiary Hainan Well Lead Medical Technology Development Co., Ltd. (referred to as \"Hainan Well Lead\") recently received the \"Medical Device Registration Certificate\" issued by the Hainan Provincial Drug Administration, with the product name: Disposable Sterile Double-Lumen Laryngeal Mask Airway Catheter" datetime: "2025-09-25T08:15:04.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/258825344.md) - [en](https://longbridge.com/en/news/258825344.md) - [zh-HK](https://longbridge.com/zh-HK/news/258825344.md) --- > 支持的语言: [English](https://longbridge.com/en/news/258825344.md) | [繁體中文](https://longbridge.com/zh-HK/news/258825344.md) # Well Lead's subsidiary Hainan Well Lead has received a medical device registration certificate According to the Zhitong Finance APP, Well Lead (603309.SH) announced that its wholly-owned subsidiary Hainan Well Lead Medical Technology Development Co., Ltd. (referred to as "Hainan Well Lead") recently received the "Medical Device Registration Certificate" issued by the Hainan Provincial Drug Administration, with the product name: Disposable Sterile Double-Lumen Laryngeal Mask Airway Catheter ### 相关股票 - [Well Lead (603309.CN)](https://longbridge.com/zh-CN/quote/603309.CN.md) ## 相关资讯与研究 - [12:18 ETEurope faces a growing chronic wound crisis - time to act is now](https://longbridge.com/zh-CN/news/281218375.md) - [11:33 ETFitness, Health and Wellness Experts Team Up to 'Get Fit for No Kid Hungry' with New On-Demand Initiative](https://longbridge.com/zh-CN/news/281213207.md) - [08:38 ETAmericaWest Medical Transportation Launches SMART on FHIR App, Now Available in the Epic Showroom and on VectorCare's Marketplace](https://longbridge.com/zh-CN/news/281021636.md) - [Alphawave’s quantum-powered trading model targets €250M AUM](https://longbridge.com/zh-CN/news/281006322.md) - [02:23 ETEMA validates indication extension application for Tryngolza® (olezarsen) for the treatment of severe hypertriglyceridemia (sHTG)](https://longbridge.com/zh-CN/news/280965130.md)